Casper, a sleep startup that launched with a mattress, has closed a $55 million Series B investment round. The new investment was led by Institutional Venture Partners (IVP), and includes Leonardo DiCaprio, Tobey Maguire, Adam Levine, Scooter Braun, and Pritzker Group Venture Capital.
Sorin SpA, a global medical device company that focuses on the treatment of cardiovascular diseases, and Cyberonics Inc, a medical device company with core expertise in neuromodulation, unveiled "LivaNova" as the name of their combined company, effective at the close of their proposed merger.
Poor sleep is associated with increased risk of heart attack and stroke, according to results from the WHO MONICA study. The research was presented at EuroHeartCare 2015 by Professor Valery Gafarov, professor of cardiology at the Russian Academy of Medical Sciences in Novosibirsk, Russia.
Researchers led by Toru Takumi at the Riken Brain Science Institute in Japan have discovered a key mechanism underlying how animals keep track of the seasons. The study, published in Proceedings of the National Academy of Sciences, shows how circadian clock machinery in the brain encodes seasonal changes in daylight duration through GABA activity along with changes in the amount of chloride located inside certain neurons.
North Shore InnoVentures, a technology incubator and business accelerator, announced that, along with two of its other portfolio companies, sleep improvement wearable maker InsomniSolv Inc received a Milestone Achievement Program grants from the Massachusetts Life Sciences Center.
At the recent New York Blue Light Symposium, the International Blue Light Society outlined three measures to counter consequences of artificial illumination faced by the global community.
Researchers from the University of Leicester have suggested that a "thermosensory" gene could be responsible for changes in behavior in different climates.
SomnoMed, manufacturer of oral devices for the treatment of mild to moderate obstructive sleep apnea, now offers compliance micro-recording technology in its wearable devices.
Project Sleep, a non-profit organization dedicated to raising awareness about sleep health and sleep disorders, has selected the recipients of the 2015 Jack & Julie Narcolepsy Scholarship.
New expert recommendations for the prevention and treatment of augmentation in patients suffering from restless legs syndrome (RLS) list Horizant (gabapentin enacarbil) as a first-line therapy with a lower risk of developing augmentation.
OSA University, a dental sleep medicine team training online education center, is hosting a 1-hour webinar on CPAP Awareness, scheduled for June 30, 2015 at 6:00 PM CDT.
Nihon Kohden senior manager Dr Takuo Aoyagi has received the 2015 Institute of Electrical and Electronics Engineers (IEEE) Medal for Innovations in Healthcare Technology.
Narcolepsy Network’s annual conference brings people with narcolepsy (PWNs) and their supporters together to hear from some of the world's leading narcolepsy specialists and to share experiences with one another.
Large-scale computing power, combined with input from millions of fitness trackers, could help unlock the mysteries of our national insomnia, reports Fortune.
Time examines information from the book NurtureShock that examines the correlation between sleep and academics.
An Express news report examines a World Health Organization study that showed getting less than 7 hours of sleep can increase the risk of a heart attack or stroke.
Excessive sleepiness is the defining characteristic of hypersomnia disorders, but there is much more to understand about the category than its main symptom. A sleep disorders advocate explains why distinguishing between primary and secondary hypersomnia is crucial to diagnosing and treating patients appropriately.
When rats rest, their brains simulate journeys to a desired future such as a tasty treat, finds University College London (UCL) research funded by the Wellcome Trust and Royal Society.
The brain responds differently to stimuli when asleep than when awake, and it is not clear what brain changes happen during sleep.
New recommendations suggest that antipsychotics should not routinely be used to treat primary insomnia in adults, children, and the elderly, as reported by Medscape.